<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>I have reviewed <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in the light of recent advances </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is not as rare as general practitioners and gastroenterologists think </plain></SENT>
<SENT sid="2" pm="."><plain>Present evidence suggests that the disorder is acquired as a complication of reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The epithelium is prone to <z:mp ids='MP_0001845'>inflammation</z:mp>, ulceration, <z:mp ids='MP_0001914'>bleeding</z:mp>, stricture, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The epithelium may contain chief and/or oxyntic cells; pepsinogens are demonstrable by agar gel electrophoresis in the mucosa and Barrett's epithelium secretes pepsin and acid, and also contains gastrin by radioimmunoassay </plain></SENT>
<SENT sid="5" pm="."><plain>Pertechnetate scintigraphy in the screening of these patients may be helpful </plain></SENT>
<SENT sid="6" pm="."><plain>In the treatment of these patients, anti-reflux operations stop the progressive ascent of the heterotopic epithelium, prevent <z:mp ids='MP_0001845'>inflammation</z:mp>, and stricture formation, and lead to healing of the mucosa </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="3699">Cimetidine</z:chebi> and bethanechol along with the conventional medical regimen for reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> may also be helpful in healing the inflamed mucosa </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> in Barrett's epithelium may have a better prognosis than gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> which invade the esophagus or than <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo> </plain></SENT>
</text></document>